» Articles » PMID: 10476232

5-Azacytidine Prevents Transgene Methylation in Vivo

Overview
Journal Gene Ther
Date 1999 Sep 7
PMID 10476232
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Retroviral sequence can silence transgene expression in vitro and in vivo. We report that this effect can be efficiently prevented by in vivo administration of the demethylating agent 5-azacytidine (aza-C). We engineered the U937 human cell line with a retroviral vector consisting of the thymidine kinase suicide gene (tk), which induces sensitivity to ganciclovir (gcv) and through an IRES sequence, the bacterial beta-galactosidase gene (lacZ) as a marker gene. About 90% of the U937 cells expressed the transgene. By injecting the transduced U937 cells in severe combined immunodeficient disease (SCID) mice, we generated a tumor which, during in vivo treatment with aza-C, maintained the high expression of lacZ and tk genes at the baseline values. LacZ-positive cells in the tumour masses after death was weak (1-2%) in the control group, while in mice treated with aza-C it was maintained at 90%. The delay in tumour onset was significantly longer when animals were treated with both aza-C and gcv (P < 0.0001) compared with animals treated with gcv or with aza-C alone. The prevention of silencing phenomena has important implications for gene therapy, because an efficient transduction associated with appropriate drug therapy, might be a powerful strategy for successful application of gene therapy protocols.

Citing Articles

Exposure to hypomethylating agent, 5-azacytidine, may improve iCasp9 suicide gene therapy for treating GvHD in allografts.

Bole-Richard E, Gamonet C, Certoux J, Idirene I, Larosa F, Deconinck E Gene Ther. 2016; 23(8-9):664-72.

PMID: 27111151 DOI: 10.1038/gt.2016.39.


DNA methylation and histone modifications are the molecular lock in lentivirally transduced hematopoietic progenitor cells.

Ching Ngai S, Rosli R, Al Abbar A, Abdullah S Biomed Res Int. 2015; 2015:346134.

PMID: 25961011 PMC: 4417590. DOI: 10.1155/2015/346134.


Irradiation, cisplatin, and 5-azacytidine upregulate cytomegalovirus promoter in tumors and muscles: implementation of non-invasive fluorescence imaging.

Kamensek U, Sersa G, Vidic S, Tevz G, Kranjc S, Cemazar M Mol Imaging Biol. 2010; 13(1):43-52.

PMID: 20396957 PMC: 3023030. DOI: 10.1007/s11307-010-0300-6.


Reporter gene-expressing bone marrow-derived stromal cells are immune-tolerated following implantation in the central nervous system of syngeneic immunocompetent mice.

Bergwerf I, De Vocht N, Tambuyzer B, Verschueren J, Reekmans K, Daans J BMC Biotechnol. 2009; 9:1.

PMID: 19128466 PMC: 2630974. DOI: 10.1186/1472-6750-9-1.


Plasmid-based genetic modification of human bone marrow-derived stromal cells: analysis of cell survival and transgene expression after transplantation in rat spinal cord.

Ronsyn M, Daans J, Spaepen G, Chatterjee S, Vermeulen K, DHaese P BMC Biotechnol. 2007; 7:90.

PMID: 18078525 PMC: 2225398. DOI: 10.1186/1472-6750-7-90.